Yang, F., Zhang, Y., Wei, Q., Liu, N., Zou, Y., Li, Y., Jiang, S. (2026). Genomic and immunogenomic characteristics of
                    <i>KRAS</i>
                    -altered ovarian cancer in a Chinese real-world cohort: Implications for precision therapy in the era of KRAS inhibitors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e17589